News about GMP/cGMP

25.09.2020

Swissmedic: Warning from Brazil due to counterfeit medicinal products from Turkish wholesalers

The Brazilian health regulatory agency, ANVISA, warns of counterfeit medicinal products for which import was banned immediately.
This was announced by Swissmedic, who was informed directly by ANVISA on 23 September 2020. 

The medicinal products were imported by the following Turkish wholesalers:  

  • Ankara Turkeli Ecza Deposu Ltd.Sti  
  • Poros Pharma  
  • Karen Ilac Ecza Deposu Ithalate Ihracat A.S.  

These medicinal products are affected:  

  • Defibrotide (batch 0126)  
  • Soliris (batch 1000706, 1003254)   
  • Harvoni (batches 22VMYA12, 61264902)  

A batch of Soliris was also obtained by a wholesaler from Switzerland and sold to Brazil.    

Swissmedic points out once again that the responsibility for obtaining only medicinal products of high quality and ensuring that the source of supply is qualified accordingly lies with the holders of the authorization for distribution. 


Source:

Swissmedic: Falsified medicinal products – information concerning an official warning from Brazil regarding three Turkish wholesalers 

 

 



Comments

No comment has yet been written about this news


Write your comment about this news